Home / For clinicians / Conditions / Neurology
Neurology
4 conditions and 8 prescribing guides so far.
By specialty and condition
Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials.
Prescribing guides
The first 90 days from the prescriber's side, built from the current label, the drugmaker's program and one public insurer policy.
ALS with a SOD1 mutation
Qalsody (tofersen)Intrathecal Dosing, Warnings and PANo REMS and no lab gate; a documented SOD1 mutation, a site with clinicians experienced in lumbar puncture, prior authorization, and pre- and post-procedure evaluation at each dose.Generalized myasthenia gravis
Imaavy (nipocalimab-aahu)Dosing, Infusion Monitoring and PANo REMS. Prior authorization, age-appropriate vaccines before initiation, a site of care (office, infusion center or home), and no active infection on each dose day.Rystiggo (rozanolixizumab-noli)Dosing Cycles, Administration and PANo REMS. Prior authorization, ONWARD Start Form with antibody report, healthcare provider administration only (office, infusion center, hospital outpatient or home infusion nurse), limited specialty pharmacy network or buy and bill, and no active infection on each dose day.Vyvgart (efgartigimod alfa)Dosing Cycles, Sites of Care and PANo REMS. Prior authorization, a site of care (infusion center, office, home nurse, or prefilled syringe self-injection after specialty pharmacy training), and no active infection on each dose day.Zilbrysq (zilucoplan)REMS, Vaccine Timing and PA CriteriaREMS-certified prescriber; meningococcal ACWY and B vaccination at least 2 weeks before day 1, or antibacterial prophylaxis with vaccines as soon as possible; baseline lipase and amylase; counseling with the Patient Guide and Safety Card; dispensing only through PANTHERx Rare after it documents vaccination status with the office.Neuromyelitis optica spectrum disorder (NMOSD)
Enspryng (satralizumab-mwge)Screening, Liver Labs and PA CriteriaNo REMS. HBV, TB and liver transaminase plus bilirubin screening before dose 1, live vaccines at least 4 weeks before, ENSPRYNG Start Form, prior authorization, and HCP-guided first injection.Uplizna (inebilizumab-cdon)Pre-Infusion Screening and PA CriteriaNo REMS. HBV, quantitative immunoglobulin and TB screening before dose 1, immunizations at least 4 weeks before, prior authorization, a site of care, and no active infection on each dose day.Relapsing multiple sclerosis (MS)
Kesimpta (ofatumumab)HBV Screening, Loading Doses and PANo REMS. HBV, quantitative immunoglobulin and liver tests before dose 1, live vaccines at least 4 weeks and inactivated at least 2 weeks before when possible, prior authorization, a supervised first injection, and no active infection on each dose day.